Your browser doesn't support javascript.
loading
Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice.
Ji, Xi-Wei; Ji, Shuang-Min; Li, Run-Tao; Wu, Ke-Hua; Zhu, Xiao; Lu, Wei; Zhou, Tian-Yan.
Affiliation
  • Ji XW; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100191, China.
  • Ji SM; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Li RT; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Wu KH; State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China.
  • Zhu X; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Lu W; School of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
  • Zhou TY; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Acta Pharmacol Sin ; 37(6): 825-33, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27133303

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Breast / Breast Neoplasms / ErbB Receptors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Breast / Breast Neoplasms / ErbB Receptors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication: